Compounds for the treatment of inflammatory disorders
US7879997B2 · kind B2 · utility
0Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2006 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | May 9, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of the Formula (I):or a pharmaceutically acceptable salt, solvate or isomer thereof, wherein n, M, V, T, W, X, U, R1 and R2 are as disclosed in the present specification, and which compounds are useful for the treatment of diseases or conditions mediated by MMPs, TNF-α or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.